文献速递烧伤创面修复

英国三级烧伤中心溴elain酶性清创早期经验:回顾性病例系列

Early experiences using bromelain-based enzymatic debridement in a tertiary burns centre in the United Kingdom: A retrospective case series review.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2020-12-15

作者认为NXB可作为现代烧伤外科的有用辅助手段,但尚不能替代标准手术。

要点

  • NXB酶性清创成功率为55%,部分患者因此避免焦痂切开。
  • 使用正性肌力药与NXB失败相关(p=0.015)。

核心结论

  • 现有证据不能以NXB替代当前标准手术治疗,但酶性清创可作为现代烧伤外科的有用辅助手段。

主要发现

  • 入院时平均总烧伤面积(TBSA)为20%,NXB治疗的平均TBSA为8.2%,通常在入院24小时内进行。
  • NXB清创在55%患者中成功,部分患者因此避免焦痂切开。
  • 使用正性肌力药与NXB失败相关(p=0.015),平均住院日29天。

临床怎么用

  • NXB酶性清创可作为烧伤外科的辅助手段,尤其适用于部分选择性病例,但需权衡再手术风险。
  • 面部烧伤使用NXB后需进一步手术的比例较高,临床决策时应谨慎。
  • 使用正性肌力药的患者NXB失败风险增加,需个体化评估。

局限性

  • 回顾性病例系列,样本量小(20例),结果需更大样本研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The modern ethos of burn care requires a holistic approach that helps patients to not only survive but also maintain a good quality of life. Bromelain-based enzymatic debridement with Nexobrid™ (NXB) has been shown to selectively debride burnt tissue and allow dermal preservation, which has the potential to reduce surgical burden and improve scarring. In this study, early experience with the use of Nexobrid™ at a tertiary burns centre between July 2016 and December 2019 is presented. In particular, the study assessed whether NXB had changed the acute care delivered to this cohort. METHODS: A retrospective analysis of the patients' records was performed. Results were analysed and presented in the context of current literature. RESULTS: Twenty adult patients (17 male, 3 female) underwent enzymatic debridement with NXB. Median age was 42.5 years. Mean total burn surface area (TBSA) on admission was 20%. Twelve patients were admitted to the intensive care unit, and eight were admitted to the adult burns ward. Mean TBSA treated with NXB was 8.2%, usually within 24 h of admission (mean). All patients had anaesthetist-led analgesia. NXB debridement was successful in 55% of patients, obviating the need for escharotomy in some patients. Sixty percent of all patients required further surgery, and 80% of facial burns treated with NXB required further surgery. Inotrope support was associated with NXB failure (p = 0.015). Mean length of stay was 29 days. DISCUSSION: Current evidence, including our own findings, cannot justify replacing the current surgical standard of care with NXB, but it certainly solidifies enzymatic debridement as a useful adjunct that should form part of the modern burn surgeon's armamentarium.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Arkoulis N, Mabvuure NT, Smith A, et al. Early experiences using bromelain-based enzymatic debridement in a tertiary burns centre in the United Kingdom: A retrospective case series review. J Plast Reconstr Aesthet Surg. 2020. PMID: 33388270. doi:10.1016/j.bjps.2020.12.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。